ArticleCurrent neuropharmacology2019

Omics-based Biomarkers for the Early Alzheimer Disease Diagnosis and Reliable Therapeutic Targets Development.

Carmen Peña-Bautista et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.